Insider Trading & Ownership - Rubin Marc

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rubin Marc

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-24
Option Award
2024-02-07
4:51 pm
N/A
2034-01-24
GALECTIN THERAPEUTICS INCGALTRubin Marc
Director
50,000$050,000
(Direct)
View
2023-01-26
Option Award
2023-01-30
4:47 pm
N/A
2033-01-26
GALECTIN THERAPEUTICS INCGALTRubin Marc
Director
40,000$040,000
(Direct)
View
2023-01-23
Option Award
2023-01-24
4:14 pm
N/A
2033-01-22
CURIS INCCRISRubin Marc
Director
85,000$085,000
(Direct)
View

Ownership(A)
2022-12-02
11:32 am
N/A
N/A
Medicine Man Technologies Inc.SHWZRubin Marc
Incorrect Filing
0$00
(Indirect)
View

Ownership
2022-11-07
9:58 pm
N/A
N/A
Medicine Man Technologies Inc.SHWZRubin Marc
Director
10% Owner
0$024,532,330
(Indirect)
View
2022-01-31
Option Award
2022-01-31
5:33 pm
N/A
2032-01-30
CURIS INCCRISRubin Marc
Director
85,000$085,000
(Direct)
View
2022-01-24
Option Award
2022-01-25
4:35 pm
N/A
2032-01-24
GALECTIN THERAPEUTICS INCGALTRubin Marc
Director
40,000$040,000
(Direct)
View
2022-01-05
Option Award
2022-01-05
6:48 pm
N/A
2032-01-05
TITAN PHARMACEUTICALS INCTTNPRubin Marc
Executive Chairman
65,000$065,000
(Direct)
View
2021-03-25
Option Award
2021-03-29
4:35 pm
N/A
2031-03-25
GALECTIN THERAPEUTICS INCGALTRubin Marc
Director
110,000$0110,000
(Direct)
View
2021-02-10
Option Award
2021-02-11
06:26 am
N/A
2031-02-10
TITAN PHARMACEUTICALS INCTTNPRubin Marc
Executive Chairman
150,000$0150,000
(Direct)
View
2021-01-28
Option Award
2021-01-29
4:30 pm
N/A
2031-01-27
CURIS INCCRISRubin Marc
Director
33,000$033,000
(Direct)
View
2020-03-02
Option Award
2020-03-04
5:10 pm
N/A
2030-03-01
CURIS INCCRISRubin Marc
Director
180,000$0180,000
(Direct)
View
2020-01-09
Option Award
2020-01-13
6:01 pm
N/A
2030-01-09
GALECTIN THERAPEUTICS INCGALTRubin Marc
Director
30,000$030,000
(Direct)
View
(A) Indicate amendment filing.